SCHEMBL27166396

SCHEMBL27166396

CC(C)(C)C1CC(COC2CCNCC2)CCN1C(=O)O

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 5/20 0.32
ITGA2B P08514 5/20 0.32
GPR119 Q8TDV5 2/20 0.31
GNAI3 P08754 1/20 0.31
GNAO1 P09471 1/20 0.31
GNAI1 P63096 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23788172 0.82 ITGB3 (0.37) ITGB3ITGA2BGNAI3GNAO1GNAI1
SCHEMBL7257968 0.81 ITGB3 (0.48) ITGB3ITGA2BGNAI3GNAO1GNAI1
SCHEMBL6216494 0.80 ITGB3 (0.39) ITGB3ITGA2BGNAI3GNAO1GNAI1
SCHEMBL21998060 0.79
SCHEMBL6775330 0.78
SCHEMBL1810381 0.78 NR1H2 (0.33)
SCHEMBL21997887 0.75
SCHEMBL18322450 0.75 RIPK1 (0.34)
SCHEMBL1206044 0.74 GNAI3 (0.37) ITGB3ITGA2BGNAI3GNAO1GNAI1
SCHEMBL3586527 0.74 RIPK1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 EP disclosed